Puberty, Precocious Clinical Trial
Official title:
First Observatory of Precocious and Advanced Puberty in Private Healthcare.
The age of puberty has fluctuated throughout history. Recent data shows an increase in the age of onset of puberty signs, in the United States but also in Europe. A recent Public Health France study published in 2018 reports an increase in the incidence of precocious puberty with geographical heterogeneity. The consequences of these appearances include the early onset of menarche, short adult height and the psychological impact. Due to a lack of studies and additional data, the reasons for this development are difficult to understand. Among current hypotheses, the entanglement with the evolution of our environment is at the forefront: the action of environmental endocrine disruptors and nutritional factors could play a role in the process of early appearance of pubertal signs. The establishment of a national observatory for early and advanced puberty in collaboration with pediatric endocrinologists (on the front line) would allow a reliable and precise field approach, capable of supplementing epidemiological data, which are currently insufficient. The investigators hypothesize that the establishment of an observatory of pubertal advances (early puberty and advanced puberty) in private medicine is possible, with inclusion of at least 75% of eligible patients, and collection of at least 80% of data.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05957991 -
Danish Precocious Puberty Study - DAPP Study A National Cohort Study on Incidence and Etiologies for Precocious Puberty
|
||
| Completed |
NCT04012632 -
Kisspeptin/GPR54 Pathway and Early Puberty
|
||
| Completed |
NCT00094328 -
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
|
Phase 2 | |
| Completed |
NCT02431416 -
Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty
|
N/A | |
| Recruiting |
NCT06083415 -
Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context
|
N/A | |
| Completed |
NCT00635817 -
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
|
Phase 3 | |
| Completed |
NCT00278915 -
Faslodex in McCune-Albright Syndrome
|
Phase 2 | |
| Completed |
NCT00494169 -
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
|
||
| Completed |
NCT00660010 -
Study of Lupron Depot In The Treatment of Central Precocious Puberty
|
Phase 3 | |
| Recruiting |
NCT04884620 -
The 3rd COPENHAGEN Puberty Study
|
||
| Active, not recruiting |
NCT03628937 -
The Effect of Decaffeinated Green Tea Polyphenol Intake on the Risk of Precocious Puberty Among Obese Girls
|
N/A | |
| Enrolling by invitation |
NCT02790112 -
Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty
|
N/A |